Vaxart, Inc. is an innovative clinical-stage biotechnology company headquartered in South San Francisco, California, dedicated to transforming vaccination methodologies through its proprietary oral recombinant protein vaccine platform. By developing oral vaccines that target significant unmet medical needs, particularly in the realms of viral infections and gastrointestinal diseases, Vaxart aims to improve immunization strategies and patient compliance. With a robust commitment to research and development, Vaxart is poised to become a key player in the vaccine sector, addressing pressing public health challenges with its pioneering approaches. Show more

Location: 170 HARBOR WAY, SOUTH SAN FRANCISCO, CA, UNITED STATES, 94080, South San Francisco, CA, 94080, USA | Website: https://vaxart.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

134.2M

52 Wk Range

$0.26 - $0.84

Previous Close

$0.58

Open

$0.58

Volume

393,218

Day Range

$0.56 - $0.61

Enterprise Value

129.1M

Cash

16.88M

Avg Qtr Burn

N/A

Insider Ownership

0.85%

Institutional Own.

1.00%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
VXA-CoV2-1 oral pill Details COVID-19	Phase 2b Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Monovalent Norovirus Vaccine Details Norovirus	Phase 2b Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
VXA-A1.1 Details Influenza	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Oral Bivalent Norovirus Vaccine Details Norovirus	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Second Generation Oral Norovirus Vaccine Details Norovirus	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Oral Bivalent Norovirus Vaccine Details Norovirus	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.